Matteo Carlino
@MattCarlino
Followers
232
Following
534
Statuses
132
Medical Oncologist, Westmead and Blacktown Hospitals, Melanoma Institute Australia
Sydney, New South Wales
Joined October 2016
RT @JaniceM10: Another important analysis led by @MattCarlino featuring contributions from our team @Perlmutter_CC. Outcomes following l…
0
4
0
RT @OzmosiHealth: $IDYA IDEAYA has been recommended to move forward with a dose in Part 2a of the trial combining Darovasertib and Crizotin…
0
4
0
RT @OmidHamidMD: IBI363 PD-1/IL2α bispecific FDA Fast Track Designation for Advanced/Metastatic #Melanoma (DCR) 73.0%. Among 8 immuno-onc…
0
5
0
RT @JaniceM10: I went through my workday with a heavy heart. I can’t believe you, my work partner, are not right down the hall to talk scie…
0
8
0
RT @ProfGLongMIA: So proud of our work @NKI_nl @MelanomaAus for #Nadina trial. #neoadjuvant #checkpoint #immunotherapy 68% decrease risk o…
0
43
0
RT @MelanomaAus: A clinical trial, developed by MIA in collaboration with int’l colleagues, has been named by @NatureMedicine as one of 11…
0
19
0
RT @DKarikios: It is time for this to change. I know @NSWHealth and @ChrisMinnsMP can do this. Those that need care and work in Western Syd…
0
5
0
RT @DrBetofMDPhD: Our newest collaboration with @amenzies9 @AdrianaHepner @MattCarlino @mcquadeMDLAc @alexshoushtari etc. is online. Insigh…
0
8
0
RT @MelanomaAus: We welcome Fed Govt's anncmnt today for funding of additional 100 #CancerNurses, in addition to 35 national melanoma nurse…
0
1
0
Congratulations
Congrats to @ProfGLongMIA & @ProfRScolyer, tonight jointly named 2024 NSW @ausoftheyear. What an incredible & inspiring group of nominees. Award is testament to Richard & Georgina’s dedication to life-saving cancer research & treatment, for melanoma & now brain cancer. So proud!
0
0
2
RT @ProfRScolyerMIA: Team from @MelanomaAus gave superb world stage preso’s at #SMR2023 in #Philadelphia including @ProfGLongMIA keynote ad…
0
12
0
Great study to be involved with. Novel design of ADC delivered targeted therapy, hopefully the first of many in melanoma and beyond.
Fabulous data on #uveal #melanoma - great tumour reduction in ph1 #clinical #trial of DYP688 presented by colleague from @MelanomaAus - @MattCarlino @SocietyMelanoma. Responses seen and so far, durable!
0
2
22
RT @ProfGLongMIA: Fabulous data on #uveal #melanoma - great tumour reduction in ph1 #clinical #trial of DYP688 presented by colleague from…
0
12
0
Congratulations to @ProfRScolyerMIA for his 2023 @SocietyMelanoma life time achievement award. Standing ovation from the room. @MelanomaAus @ProfGLongMIA @amenzies9
0
8
71
RT @FunchainMD: Doing as Meenhard asked - enjoying the good company of the melanoma community to foster collaboration not competition #SMR2…
0
3
0
RT @DoniaMarco: #Melanoma at #ESMO23: Unprecedented response rates in patients with uveal melanoma treated with a combo of TKI. ❕ORR 30% ‼️…
0
18
0
RT @HTawbi_MD: pKC inhibitor darovasertib + crizotinib Phase 2 presented by @MeredithMcKean formerly at @MDAndersonNews. Manageable toxicit…
0
7
0
Well deserved Oliver and team a great trial to be involved with
Congratulations team - I'm thrilled to see the work of the group recognised. So sorry I couldn't be there to enjoy the moment with you all!
0
0
1
RT @ulurustatement: OUR NEW AD IS LIVE! You’re the Voice that will make history. On 14 October, we know we all can stand together with…
0
5K
0